AI tool uses AlphaFold3 to pinpoint exactly which gene editor residues cause off-target cuts

Key Findings

💉 Base Editing Has Its First Real Clinical Wins — and a Clear Checklist of What's Left

• A comprehensive review in Cell Genomics maps early clinical success in sickle cell disease, beta-thalassemia, leukemia, and high cholesterol — all using base editors that install single-letter DNA fixes without cutting both strands.
• Remaining blockers are specific: unintended edits within the editing window, payload size limits for delivery vehicles, immunogenicity, and the absence of long-term safety data across diverse cell types.

🔬 One Enzyme, Ten Knockouts, Fewer Chromosomal Disasters

• A new platform called BEKI repurposes a base editor's Cas9 nickase to insert a therapeutic gene at one site while simultaneously disrupting up to 10 other genes — all with a single enzyme, no viral vector.
• Compared to standard Cas9 multiplex editing, BEKI markedly reduced chromosomal translocations while keeping cells viable, and produced allogeneic CAR T cells with enhanced cytokine secretion and resistance to immune rejection.

🌿 Potato Gets a Precision Upgrade — 76.7% Editing Efficiency

• Researchers optimized cytosine base editors for potato — the world's third most important food crop — by stacking four improvements: a stronger promoter, a viral enhancer, chromatin-modulating peptides, and a human RNA demethylase gene to open chromatin.
• The combination lifted average editing efficiency from 26.8% to 76.7% in a hairy root assay, and delivered 85.7% efficiency for simultaneous edits in two herbicide-resistance genes.

🧬 Bacteria Have Been Running a Hidden Immune Coordination System

• A Nature study describes CRISIS — a regulatory paradigm where type I CRISPR-Cas loci embed and control diverse innate defense systems inside bacteria. Small RNA guides direct the CRISPR machinery to suppress promoters of other immune cassettes, keeping them at low baseline activity.
• When CRISPR-Cas is disabled — by mutation or anti-CRISPR proteins — those embedded defenses surge, trading host fitness for higher immune output. It functions like a layered prokaryotic immune guard.

⚖️ Heritable Gene Editing Ethics: A New Framework That Splits the Category

• A review in Med argues that heritable genome editing should not be treated as a single prohibited category. For catastrophic monogenic conditions where embryo selection cannot yield unaffected offspring, the authors contend that editing may be ethically permissible — and that failing to pursue it responsibly could itself be an ethical failure.
• For polygenic interventions, they call clinical application premature due to insufficient predictive validity; for non-disease enhancement, the case is weaker still given positional benefits and stratification risks.

📊 Addgene Hit 300,000 CRISPR Plasmid Shipments — Here's What the Data Reveals

• Addgene's distribution data across more than 20,000 deposited CRISPR plasmids from over 1,000 labs shows diversification well beyond Cas9: Cas12, base editing, prime editing, epigenetic tools, and CRISPRi/a are all growing in share.
• Guide RNA and HDR templates dominate deposits; cloning backbones are most requested; and relative distribution outside the US and China is rising — a sign of broader global adoption.